Sugio K - Search Results

1

Smoking cessation program and CYP2A6 polymorphism.

Ozaki S, Oyama T, Isse T, Kagawa N, Uramoto H, Sugio K, Yasumoto K, Kono K, Kawamoto T. Ozaki S, et al. Among authors: sugio k. Front Biosci. 2006 Sep 1;11:2590-7. doi: 10.2741/1993. Front Biosci. 2006. PMID: 16720336 Clinical Trial.

2

Tissue-distribution of aldehyde dehydrogenase 2 and effects of the ALDH2 gene-disruption on the expression of enzymes involved in alcohol metabolism.

Oyama T, Isse T, Kagawa N, Kinaga T, Kim YD, Morita M, Sugio K, Weiner H, Yasumoto K, Kawamoto T. Oyama T, et al. Among authors: sugio k. Front Biosci. 2005 Jan 1;10:951-60. doi: 10.2741/1589. Print 2005 Jan 1. Front Biosci. 2005. PMID: 15569633

3

Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer.

Oyama T, Morita M, Isse T, Kagawa N, Nakata S, So T, Mizukami M, Ichiki Y, Ono K, Sugaya M, Uramoto H, Yoshimatsu T, Hanagiri T, Sugio K, Kawamoto T, Yasumoto K. Oyama T, et al. Among authors: sugio k. Front Biosci. 2005 May 1;10:1156-61. doi: 10.2741/1608. Front Biosci. 2005. PMID: 15769614

4

Expression of aldehyde dehydrogenase 2 in the normal esophageal epithelium and alcohol consumption in patients with esophageal cancer.

Morita M, Oyama T, Kagawa N, Nakata S, Ono K, Sugaya M, Uramoto H, Yoshimatsu T, Hanagiri T, Sugio K, Kakeji Y, Yasumoto K. Morita M, et al. Among authors: sugio k. Front Biosci. 2005 Sep 1;10:2319-24. doi: 10.2741/1700. Front Biosci. 2005. PMID: 15970497

5

Cytochrome P450 expression (CYP) in non-small cell lung cancer.

Oyama T, Sugio K, Uramoto H, Kawamoto T, Kagawa N, Nadaf S, Carbone D, Yasumoto K. Oyama T, et al. Among authors: sugio k. Front Biosci. 2007 Jan 1;12:2299-308. doi: 10.2741/2232. Front Biosci. 2007. PMID: 17127240

6

Increased cytochrome P450 and aryl hydrocarbon receptor in bronchial epithelium of heavy smokers with non-small cell lung carcinoma carries a poor prognosis.

Oyama T, Sugio K, Uramoto H, Iwata T, Onitsuka T, Isse T, Nozoe T, Kagawa N, Yasumoto K, Kawamoto T. Oyama T, et al. Among authors: sugio k. Front Biosci. 2007 May 1;12:4497-503. doi: 10.2741/2404. Front Biosci. 2007. PMID: 17485391

7

Expression of cytochrome P450 in non-small cell lung cancer.

Oyama T, Sugio K, Isse T, Matsumoto A, Nose N, Uramoto H, Nozoe T, Morita M, Kagawa N, Osaki T, Muto M, Yasumoto K, Kawamoto T. Oyama T, et al. Among authors: sugio k. Front Biosci. 2008 May 1;13:5787-93. doi: 10.2741/3116. Front Biosci. 2008. PMID: 18508622 Review.

8

Evidence-based prevention (EBP): approach to lung cancer prevention based on cytochrome 1A1 and cytochrome 2E1 polymorphism.

Oyama T, Matsumoto A, Isse T, Kim YD, Ozaki S, Osaki T, Sugio K, Yasumoto K, Kawamoto T. Oyama T, et al. Among authors: sugio k. Anticancer Res. 2003 Mar-Apr;23(2C):1731-7. Anticancer Res. 2003. PMID: 12820449 Review.

9

Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese.

Uramoto H, Sugio K, Oyama T, Ono K, Sugaya M, Yoshimatsu T, Hanagiri T, Morita M, Yasumoto K. Uramoto H, et al. Among authors: sugio k. Lung Cancer. 2006 Jan;51(1):71-7. doi: 10.1016/j.lungcan.2005.08.006. Epub 2005 Sep 29. Lung Cancer. 2006. PMID: 16198442

10

Expression of aromatase CYP19 and its relationship with parameters in NSCLC.

Oyama T, Kagawa N, Sugio K, Uramoto H, Hatano O, Harada N, Kaneko K, Kawamoto T, Yasumoto K. Oyama T, et al. Among authors: sugio k. Front Biosci (Landmark Ed). 2009 Jan 1;14(6):2285-92. doi: 10.2741/3379. Front Biosci (Landmark Ed). 2009. PMID: 19273201 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

335 results

Search Page